Skip to main content

Table 3 Patient data collected in patient review

From: A survey of severe asthma in Canada: results from the CASCADE practice reflective program

 

Never used a biologic (n = 152)

Biologic in the past (n = 26)

Currently using biologic (n = 325)

All patients (n = 503)

What asthma phenotype would you say this patient has?

 Allergic

11%

19%

13%

12%

 Eosinophilic

18%

15%

29%

25%

 Mixed

48%

58%

54%

53%

 Non-type 2

20%

4%

4%

9%

 Other

3%

4%

0%

1%

How many exacerbations requiring oral corticosteroids has the patient had in the past 12 months?

 None

28%

35%

45%

39%

 1

15%

4%

14%

14%

 2–3

46%

46%

31%

36%

 More than 3

11%

15%

10%

11%

Has the patient been hospitalized in the past 12 months due to an asthma exacerbation?

 Yes

14%

15%

13%

14%

 No

85%

81%

86%

86%

 Unknown

1%

4%

0%

1%

What is the patient's latest ACQ score?

 0 to < 0.75

3%

4%

13%

9%

 0.75 to < 1.5

5%

0%

9%

7%

 1.5 or more

32%

27%

19%

23%

Not Available

60%

69%

60%

60%

What is the patient's latest Sputum Eosinophils?

 < 3%

2%

0%

2%

2%

 3% to 10%

2%

4%

1%

1%

 > 10%

1%

4%

2%

2%

 Not available

95%

92%

95%

95%

What is the patient's latest FeNO?

 < 20 ppb

5%

8%

10%

9%

 20 ppb or more

14%

19%

15%

15%

 Not available

81%

73%

75%

77%

What is the patient's latest FEV1?

 Median % of predicted

70%

69%

78%

75%

 Median Volume

2.0 L

2.0 L

2.2 L

2.1 L

 Not available

9%

12%

7%

8%

What is the patient’s latest Skin Prick Test Result?

 Positive

55%

62%

60%

58%

 Negative

14%

12%

13%

13%

 Not available

31%

27%

27%

28%

What is the patient's latest absolute blood eosinophil count?

 Mean

354 cells/µL

379 cells/µL

479 cells/µL

436 cells/µL

 < 150 cells/µL

29%

19%

30%

29%

 150 to < 300 cells/µL

19%

19%

10%

14%

 > 300 cells/µL

48%

58%

55%

53%

Not Available

4%

4%

4%

4%